Skip to main content
. 2020 Aug 25;10:1451. doi: 10.3389/fonc.2020.01451

Figure 1.

Figure 1

Expression of EGFL6 in different ovarian cancer cells and ovarian cancer tumors from different patients. (A) Immunohistochemistry assay of protein expression of EGFL6 in four patient ovarian cancer tissues and one normal ovarian tissue sample. (a) Normal human ovarian tissue, (b) moderately differentiated mucinous adenocarcinoma, (c) ovarian clear cell carcinoma, (d) poorly differentiated malignant tumor, and (e) high-grade serous papillary carcinoma. (B) EGFL6 expression levels analyzed by Western blot in different ovarian cancer cells. (C) Quantitative analysis of EGFL6 expression in different ovarian cancer cells.